We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

By LabMedica International staff writers
Posted on 01 May 2025

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. More...

Optical spectroscopy, which involves shining a laser on a material and observing how light interacts with it, is a widely used technique in chemistry, materials science, and medicine. However, interpreting the resulting spectral data can be challenging and time-consuming, especially when the differences between samples are subtle. Now, a new machine learning (ML) algorithm has been developed to effectively interpret the "light signatures" or optical spectra of molecules, materials, and disease biomarkers, offering the potential for faster and more precise medical diagnoses and sample analysis.

The algorithm, known as Peak-Sensitive Elastic-net Logistic Regression (PSE-LR), was developed by researchers at Rice University (Houston, TX, USA) specifically to analyze light-based data. PSE-LR is not only capable of accurately classifying different samples but also offers transparency in its decision-making process, a feature that many advanced ML models typically lack. The algorithm provides a "feature importance map" that highlights the specific parts of the spectrum that contributed to a particular classification decision, making the results easier to interpret, verify, and act upon. In tests comparing PSE-LR to other ML models, it demonstrated superior performance, particularly in identifying subtle or overlapping spectral features.

The model also excelled in various real-world tests, including detecting ultralow concentrations of the SARS-CoV-2 spike protein in fluid samples, identifying neuroprotective solutions in mouse brain tissue, classifying Alzheimer’s disease samples, and differentiating between 2D semiconductors. This new algorithm could pave the way for the creation of novel diagnostics, biosensors, or nanodevices. The optical spectra of tissues or other biological samples can provide valuable insights into what is happening within the body. This capability is critical because quicker and more accurate disease detection can lead to improved treatments and potentially save lives. Beyond healthcare, the method can also aid scientists in better understanding new materials, facilitating the development of smarter biosensors and more effective nanodevices.

“Imagine being able to detect early signs of diseases like Alzheimer’s or COVID-19 just by shining a light on a drop of fluid or a tissue sample,” said Ziyang Wang, an electrical and computer engineering doctoral student at Rice who is a first author on a study published in ACS Nano. “Our work makes this possible by teaching computers how to better ‘read’ the signal of light scattered from tiny molecules.”


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Plasmodium Test
Plasmodium DNA Real Time PCR Kit
New
See-Saw Rocking Shaker
SH-200D-S-L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Molecular Diagnostics

view channel
Image: A family of molecules could help diagnose and treat breast cancer (Photo courtesy of Shutterstock)

Molecular Biomarkers Pave Way for New Tests to Diagnose and Predict Breast Cancer

Despite playing essential roles in tissue development and immune protection, the contribution of proteoglycans in cancer remains poorly understood. Some proteoglycans appear to shield the body from cancer,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: T cell immunity could be a marker for early Parkinson’s treatment (Photo courtesy of Shutterstock)

T Cells in Blood Can Detect Parkinson's Years Before Diagnosis

Diagnosing Parkinson’s disease before the appearance of motor symptoms remains one of neurology’s most significant challenges. Patients can go years—even decades—without a diagnosis, as subtle early indicators... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.